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Abstract
Background: In an increasing aging society, reduced mobility is one of the most important factors limiting activities of
daily living and overall quality of life. The ability to walk independently contributes to the mobility, but is increasingly
restricted by numerous diseases that impair gait and balance. The aim of this cross-sectional observation study was to
examine whether spatio-temporal gait parameters derived from mobile instrumented gait analysis can be used to
measure the gait stabilizing effects of a wheeled walker (WW) and whether these gait parameters may serve as
surrogate marker in hospitalized patients with multifactorial gait and balance impairment.
Methods: One hundred six patients (ages 68–95) wearing inertial sensor equipped shoes passed an instrumented
walkway with and without gait support from a WW. The walkway assessed the risk of falling associated gait parameters
velocity, swing time, stride length, stride time- and double support time variability. Inertial sensor-equipped shoes
measured heel strike and toe off angles, and foot clearance.
Results: The use of a WW improved the risk of spatio-temporal parameters velocity, swing time, stride length and the
sagittal plane associated parameters heel strike and toe off angles in all patients. First-time users (FTUs) showed similar
gait parameter improvement patterns as frequent WW users (FUs). However, FUs with higher levels of gait impairment
improved more in velocity, stride length and toe off angle compared to the FTUs.
Conclusion: The impact of a WW can be quantified objectively by instrumented gait assessment. Thus,
objective gait parameters may serve as surrogate markers for the use of walking aids in patients with gait
and balance impairments.
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Background
In an increasing ageing society reduced mobility is one
of the most important factors that limit activities of daily
living and overall quality of life [1]. The ability to walk
independently is crucial for the individual mobility, but
is increasingly restricted by numerous diseases that im-
pair gait and balance in elderly people [2, 3]. Gait and
balance disorders are among the most frequent impair-
ments in older adults. They are usually of multifactorial
origin, result in the loss of independence, and limited
quality of life of patients, and in particular contribute to
an increased risk of falling [4–7]. Approximately 30% of
adults aged 65 years and older report falls at least once a
year [8], with severe complications and consecutive co-
morbidities. Increased risk of falling has been associated
with distinct spatio-temporal gait parameters, such as
reduced velocity, swing time, stride length, and increased
gait variabilities of stride and double support time in eld-
erly people [8–12]. Therefore, these spatio-temporal gait
parameters are potential surrogate markers for gait defi-
cits and risk of falling [13, 14].
Several assistive devices are frequently prescribed in
gait and balance disorders in order to support the gait
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and mobility of affected patients [15–18]. Walking aids
such as crutches, canes, or 4-wheeled walkers (WW) are
suitable to reduce the dependency on care-givers and
also to decrease the burden of care allowing the patient
to remain functionally independent and mobile. Thus,
assistive devices have become an indispensable and well
accepted part within rehabilitation programs since the
1990s [19, 20]. Even though the benefit of walking aids
such as WW is generally well accepted [15, 21–23], only
little is known about the impact of these devices on gait
parameters as objective measures in geriatric patients
with gait and balance disorders.
Recent technology developments in instrumented gait
analysis provide stance-phase derived spatio-temporal
gait parameters derived from well-established instru-
mented walkways [8, 24], or novel inertial sensor based
gait analysis systems that are able to also assess swing
phase related gait parameters such as foot angles at the
beginning (toe off ) or the end (heel strike) of the swing
phase, and the toe clearance which might be also im-
portant for an increased risk of falls [25–29]. Thus,
instrumented gait analyses are easy applicable and en-
able objective measures of gait impairments and thera-
peutic effects for example in disease modifying therapies
in Parkinson’s disease [30, 31], ataxia [32], multiple
sclerosis [33], people with type II diabetes mellitus [34]
and effects of lower limp amputations [35].
Two aims were addressed in the present observational
study: (I) to investigate whether instrumented gait ana-
lysis derived gait parameters are able to objectively
measure the effect of using a WW in hospitalized geriatric
patients with gait and balance impairment of multifactor-
ial origin, and (II) to identify gait parameters as surrogate
markers for the use of a WW. To assess potential con-
founding familiarization effects we compared first time
users (FTUs) with patients who already used a WW (FUs)
even before they were admitted to the hospital.
Methods
Patient recruitment and characteristics
Between April 2012 and May 2013, 274 hospitalized
patients routinely submitted to gait and mobility assess-
ment were included in this observational study and sub-
jected to instrumented gait analysis during standardized
functional mobility laboratory testing at the Geriatrics
Centre of the Waldkrankenhaus St. Marien, Kongregation
der St. Franziskusschwestern Vierzehnheiligen, Erlangen,
Germany (Fig. 1). Geriatric hospital standard procedures
account for multifactorial gait alteration, and subject all
patients with signs of gait and balance impairment to
Fig. 1 Patients flow chart. MMSE = Mini Mental State Examination; FTU = first time wheeled walker use; FU = frequent wheeled walker user;
eGaIT = embedded Gait analysis using intelligent technology
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laboratory functional mobility assessment. It includes a
comprehensive basic geriatric assessment battery [36] and
standardized clinical and functional mobility screening as
recommended by the Medical Association for the Promo-
tion of Geriatrics in Bavaria, Germany (AFGiB). Besides
testing for visual impairment, orthostatic hypotension,
and peripheral neuropathy, functional tests in particular
include the Timed up and go (TUG), postural stability,
and gait analysis. This standard mobility assessment is ap-
plied to all hospitalized patients with gait and balance im-
pairment that are frequently use a WW (FUs), but also to
patients that use a WW for the first time (FTUs).
In our patient cohort, gait and balance impairment was
of multifactorial origin and typically associated with neuro-
degenerative diseases, peripheral (diabetic) neuropathy,
fainting or syncope, vertigo/dizzy spells, attentional or mild
cognitive deficits, multimorbidity and polypharmacy (>6
medications per day), and history of falls. Patients meeting
these diagnostic screening criteria were submitted by the
attending physician to routine diagnostics at the functional
mobility laboratory, and thus enrolled in the present obser-
vational study. Participants in our study had an average of
11 (range: 2–19) diagnoses (Table 1). The most frequent
were arrhythmia (69.9%), arterial hypertension (69.1%), gait
impairment/fall proneness (53.6%), coronary artery disease
(40.6%), and hypercholesterolemia/dyslipedemia (26.8%).
Patients (at least 65 years old) were included if they were
able to walk 10 m without assistance, understand and fol-
low verbal instructions. Patients were not included in the
study if they exhibited indications of severe pain, impaired
vision (<0125/40 Distance 5 m), severe cognitive impair-
ment (Mini-Mental State Examination (MMSE) score ≤
23) [37], acute injuries, or self-limiting conditions prevent-
ing them from performing the tests such as febrile illness,
severe headache, fatigue, vomiting and exsiccosis.
One hundred thirteen patients met the inclusion criteria
and 106 completed the instrumented gait tests (Fig. 1). Six
patients were excluded during gait analysis because of
cardiovascular complaints, orthostatic hypotension, or
general discomfort. Due to technical failure, data from
one patient examined using the instrumented walkway
and from 10 patients using eGaIT had to be excluded.
All patients gave informed consent in agreement
with the 1964 declaration of Helsinki. The study was








Gender (W/M) 60/46 37/25 23/21 0.4483
Age (years) 81.7 ± 6.2 (68.5 – 95.4) 81.8 ± 6.4 (68.5 – 95.1) 81.5 ± 5.9 (72.2 – 95.4) 0.815
Height (cm) 164.0 ± 9.8 (144 – 184) 162.3 ± 10.0 (144 – 182) 166.4 ± 9.2 (150 – 184) 0.035
Weight (kg) 71.4 ± 14.4 (43 – 110) 70.5 ± 14.4 (43 – 110) 72.5 ± 14.5 (50 – 108) 0.489
BMI (kg/m2) 26.5 ± 4.5 (17 – 38) 26.8 ± 4.8 (17 – 38) 26.1 ± 4.1 (20 – 38) 0.442
Leg length (cm) 88.9 ± 5.7 (73.3 – 100.5) 88.5 ± 5.8 (73.3 – 100.5) 89.5 ± 5.6 (78.5 – 98.5) 0.375
Clinical characteristics
MMSE 27.4 ± 1.8 (24 – 30) 27.3 ± 1.8 (24 – 30) 27.6 ± 1.7 (24 – 30) 0.347
GDS 3.3 ± 2.6 (0 – 12) 3.7 ± 2.8 (0 – 12) 2.8 ± 2.2 (0 – 9) 0.081
FES-I score 31.8 ± 10.7 (16 – 61) 33.6 ± 10.9 (16 – 61) 29.1 ± 9.9 (16 – 56) 0.036
No of medication1 8.9 ± 3.0 (2 – 18) 9.4 ± 3.1 (2 – 17) 8.3 ± 2.9 (2 – 18) 0.3153
No of diagnosis2 11.3 ± 4.0 (2 – 19) 12.1 ± 3.7 (3 – 19) 10.2 ± 4.0 (2 – 19) 0.1043
Fall history
Non fallers 52 49.1% 28 45.2% 24 54.5% 0.2463
Fallers 34 32.1% 19 30.6% 15 34.1%
Recurrent fallers 20 18.9% 15 24.2% 5 11.4%
Functional characteristics
POMA 21.1 ± 3.8 (12 – 28) 20.2 ± 3.5 (12 – 27) 22.1 ± 3.9 (12 – 28) 0.009
TUG 20.1 ± 8.1 (9 – 48) 22.5 ± 8.4 (11 – 48) 16.6 ± 6.5 (9 – 40) <0.001
BARTHEL 53.9 ± 10.8 (30 – 80) 52.5 ± 9.8 (30 – 80) 55.9 ± 11.8 (30 – 80) 0.108
Values are mean ± standard deviation and (range); Fall history = Total number and percentage. FU = frequent wheeled walker user, FTU = first time wheeled walker user,
BMI = Body-Mass-Index, MMSE = Mini Mental State Examination (range 0 – 30), GDS = Geriatric Depression Scale (range 0 – 15); FES-I = Falls Efficacy Scale International (range
16 – 64); Fall history (past 12 months): Non fallers = 0 falls; fallers = 1–2 falls; recurrent fallers =≥ 3 falls; POMA = Performance Oriented Mobility Assessment (range 0 – 28),
TUG = Timed up & Go, BARTHEL = Hamburg Classification Manual for the Barthel Index in geriatrics (range 0 – 100). 1Number of medications and 2diagnosis treated during
duration of stay.
P-value for unpaired t-test (FTU; FU); or 3Pearsons’s chi-square test for independence
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approved by the Clinical Ethics Committee of the
Faculty of Medicine, Friedrich-Alexander University
Erlangen-Nürnberg (FAU), Germany (Re.No.4208).
Clinical assessment
Cognition was examined using the Mini-Mental State
Examination (MMSE) [38]. Depression was rated using
the Geriatric Depression Scale (GDS, total score range
0–15 with scores ≥ 5 indicating possible depression) [39].
Fear of falling was assessed using the Falls Efficacy Scale
International questionnaire (FES-I), total score range
16–64, with scores ≥ 28 indicating high fall concerns
[40, 41]. Number of falls during the past 12 months
was assessed during a semi-structured interview as sug-
gested by Freiberger & Vreede, 2011 [42]. We classified
“no fallers”, “fallers” (1–2 falls/year), and “recurrent
fallers” (≥3 falls/year). To assess Activity of Daily Living
(ADL), performance was assessed using the Hamburg
Classification Manual for the Barthel Index (BARTHEL,
range 0–100); scores 0–30 indicating dependence on
care, 35–80 need for help and 85–100 needs help select-
ively to independence [43]. Evaluation of functional mobil-
ity associated with increased risk of falling was assessed
with the 28 point version Performance-Oriented Mobility
Assessment (POMA) [44]. The 3 m Timed “Up & Go” test
(TUG) was used to assess mobility and functional per-
formance [11, 45, 46].
Gait analysis
Objective gait analysis of WW assisted gait tasks was
performed by two complementary instrumented gait ana-
lysis systems: gait parameters were recorded and quanti-
fied by I) an instrumented walkway (GAITRite®) [8, 24],
and II) an inertial sensor based mobile gait analysis system
(eGaIT – embedded gait analysis system using intelligent
technology) [26, 31, 47, 48].
GAITRite walkway derived gait parameter
The five spatio-temporal risk of falling associated gait
parameters: (1) velocity (cm/s) [9, 12, 49, 50], (2) swing
time (s) [12], (3) stride length (cm) [9, 12], (4) stride time
variability (% CV) [8, 51, 52], and (5) double support
time variability (% CV) [9, 12] were recorded by an
instrumented walkway (GAITRite® walkway; Model Plat-
inum CIR Systems Inc., 8 John Walsh Blvd., Peekskill NY
10566 WA) according to the guidelines of the European
GAITRite Network Group [53]. The use of the WW in-
terfered with the correct automated detection of gait
parameters because the pressure imprint of the WW
was falsely identified as a footprint by the GAITRite®
system (Fig. 2). Therefore footprints of the gait task
with WW were manually identified by a researcher
blinded to the source of data and gait parameters were
recalculated [26].
eGaIT derived gait parameter
In addition to the spatio-temporal gait parameters we
were able to measure complementary swing phase asso-
ciated gait parameters from the sagittal plane including
(1) toe off angle: defined as the foot angle in sagittal
plane at the toe off event during gait cycle; (2) heel strike
angle: defined as the foot angle in sagittal plane at the
temporal event when the heel hits the ground; and (3)
maximal toe clearance: defined as the maximum dis-
tance between toe and ground during swing phase
(Fig. 3) using an instrumented mobile gait analysis sys-
tem (eGaIT) [26]. The mobile eGaIT gait analysis system
consists of inertial motion sensors (3-axis gyroscope
(range ± 500°/s) and a 3-axis accelerometer (range ± 6 g;
Shimmer 2R, Shimmer Sensing, Dublin, Ireland) laterally
mounted to the heel of both shoes (Fig. 3). In contrast
to the GaitRite system, the inertial motion sensors pro-
vide accelerometer and gyroscope data of the swing
phase, thus allowing to compute the three additional gait
parameters as previously described [26]. Briefly, by using
stride segmentation [47] and gait parameter calculation
algorithms [25, 54, 55], toe off and heel strike angles were
automatically calculated from the raw sensor data in
degree (°), and maximal toe clearance in cm (Fig. 3).
Calculation of these parameters has been previously vali-
dated using an optical motion capture system (Vicon
Motion Systems Ltd., UK) [48]. Using the eGaIT system
foot angle in sagittal plane is calculated with a mean abso-
lute error of 2.49° ± 1.21° and toe clearance with a mean
absolute error of 1.69 cm± 1.21 cm as described [48].
Gait test paradigm
All patients underwent standardized gait assessment over
a straight 10 m walking distance crossing the GAITRite
walkway wearing the inertial motion sensor equipped
shoes. The complete gait assessment included two gait
tests: (1) Normal walking: Patients were instructed to
cross the instrumented walkway unsupported at their self-
selected “normal” walking speed (2) walking with a WW:
The walkway was crossed with the support of the WW
(Rollator B, Modell 4003, Bischoff & Bischoff GmbH,
Karlsbad, Germany) at “normal” speed as described in (1).
All patients used the same WW model and correct handle
height was adjusted individually by measuring the distance
from the floor to the joint line of the wrist. Thereby the
patient stood upright with arms relaxed at the side of the
body [16, 56]. After the WW had been adjusted to the pa-
tient, FTUs familiarized themselves with the WW walking
for approximately 5 min. No specifically instructed prac-
tice trials were performed. Both FTU´s and FUs were
given the instructions to walk with an upright posture
while maintaining the hip between both handles of the
WW. Patients were allowed to rest between the tasks if
needed. Testing was immediately stopped if a subject
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showed signs of discomfort. Patients initiated and termi-
nated each gait task 2 m before and after the walkway to
enable steady-state walking over the GAITRite walkway.
Statistics
Comparative statistics on patient characteristics were
calculated using Pearson’s Chi-Square or Student’sT-test
as indicated. The effect of WW usage (main within-
subject effect) was calculated by ANOVA with repeated
measures using FU vs. FTU as interaction effect. Statis-
tical tests were carried out using the IBM SPSS statistics
23 program for Microsoft Windows. The level of signifi-
cance was set at p ≤ 0.05.
Results
The mean age of the cohort (n = 106) was 81.7 ± 6.2 years
with a balanced gender (56.6% women). 41.5% of all par-
ticipants were using the WW for the first time (FTUs).
No differences in gender, age, height, and weight or body
mass index were noted across the two groups (Table 1).
The number of diagnoses and medication was slightly
higher in the FUs without reaching significance. Psycho-
metric results showed that cognitive function did not
differ between FUs and FTUs (p = 0.347, MMSE score).
No or only mild levels of depression was observed in all
patients. 16 patients in the FU group were mildly de-
pressed (GDS > 5), and only 7 in the FTU subgroup
without reaching statistical significance (p = 0.207, Pear-
son’s Chi-square test).
Functional mobility assessment battery revealed stron-
ger signs of impairment in patients that were used to a
WW (FUs) compared the FTUs in several parameters.
Fear of falling assessed by the FES-I questionnaire re-
vealed an overall increased fear of falling level (mean:
31.8 ± 10.7 SD, cut off ≥ 28), which was even more pro-
nounced in the FUs compared to the FTUs. Numbers of
falls in the past 12 months were recorded and classified
into three groups. In total, 49.1% reported no falls,
32.7% experienced 1–2 falls and 18.9% reporting three
or more falls. The percentage of frequent fallers was
higher in the FU subgroup without reaching statistical
significance. Functional impairment was higher in the
FUs compared to the FTU as reflected by the POMA
(p = 0.009) and the TUG (p < 0.001) scores. Also, the
Barthel index indicating functional dependency was
lower in the FUs compared to the FTUs without
Fig. 2 GAITRite® recorded footprint and 4-wheeled walker track signals of a patient (a). After manual removal of the WW tracks the use of the
automated removal tool of the GAITRite® software caused errors in the calculation of gait parameters du to mislabeling of footprints. Therefore
footprint identification was confirmed and adjusted manual by an observer blinded to the data source. The footfalls turn color when the sensors
are activated and confirmed by the examiner. Gray = deactivated sensors, black = manually identified sensors (b). Green = activated and calculated
sensors of the left foot, magenta = activated and calculated sensors of the right foot (c)
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reaching significance (p = 0.108). In summary, FU pa-
tients accustomed to a WW showed higher functional
impairment than FTU patients not using a WW.
The complete cohort of patients with different levels
of gait impairment showed decreased spatio-temporal
gait parameters recorded from the 10 m walk (normal
walk) compared to historical normative values derived
from a healthy aged cohort reported by Hollman et al.:
velocity (109.5 cm/s), swing time (0.40 s) and stride
length (123 cm) [57]. Also, several spatio-temporal gait
parameter impairments correlated to the functional
scores FES-I, Tinetti/POMA and TUG, but not with the
Barthel index or the psychometric scores MMSE or GDI
(Additional file 1: Table S1) indicating the association of
the functional immobility levels within the patient cohort
to the gait parameter impairments which was also in line
with the routine admission procedure to functional
mobility tests within the geriatric hospital. Within the
present cohort, velocity and stride length were signifi-
cantly lower in the FUs compared to FTUs (Table 2). Also,
the novel objective inertial sensor-based mobile sagittal
plane gait parameters (e.g. toe off and heel strike angles,
and maximal toe clearance) were significantly lower in
FUs (Table 2).
We next asked whether the use of a WW improved
risk of falling associated spatio-temporal and sagittal
plane gait parameters. Thus, all patients performed a
normal walking without a WW (WW -) and a second
walk using a 4-wheeled walker (WW +). Both velocity
and stride length increased by 1.18 fold (main effect -
Table 3). Swing time increased by 1.07 fold. Stride time
and double support time variabilities, however, were not
influenced by WW use (Table 3). The use of WW also
improved the sagittal plane gait parameters toe off and
Fig. 3 Inertial sensor based gait parameter extraction paradigm. The upper plot shows an example signal of angles at toe off and heel strike and
toe clearance during the swing phase. The middle plot show an example signal of acceleration in up and down direction and lower plot shows
angular velocity in sagittal plane. The gait events heel strike (HS, X) and toe off (TO, O) are marked in the plots. Heel strike is determined from the
negative peak in the acceleration signal and toe of from the zero crossing in the angular velocity signal
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heal strike angles. No change in maximal toe clearance
was observed in all patients.
Since gait parameters improved by using a WW in all
patients, we wanted to know whether patients that were
not used to a WW before (FTUs) showed a similar im-
provement of gait parameters compared to FUs to evalu-
ate potential confounding effects of low familiarization.
In addition, we addressed the question, of whether geri-
atric patients with gait and balance impairment that
were less functionally impaired (FTUs) exhibit distinct
gait parameter changes in response to a WW use com-
pared to FUs (Table 3 – interaction effect). Importantly,
the tendency of improvement was similar between FTUs
and FUs for all spatio-temporal gait parameters and for
the foot angles. Nevertheless, the improvement in velocity,
stride length, and toe off angle was significantly higher in
FUs compared to FTUs (Table 3 – interaction effect).
Swing time improvement was similar in both groups,
whereas stride time variability and double support time
variability were not changed in both groups (Table 3).
Surprisingly, the change of maximal toe clearance was sig-
nificantly different between FUs and FTUs (Table 3, inter-
action effect). By evaluating the effect of a WW in both
groups independently revealed even a significant decrease
of maximal toe clearance in FTUs by 8% (p =0.005, un-
paired T-test), while the FUs showed no difference.
Table 2 Gait parameters in FU and FTU
Normal Walk
Total FU FTU Significance
Variable n = 106 n = 62 n = 44 p-value
Spatio-temporal gait parameters Mean ± SD Mean ± SD Mean ± SD p
Velocity (cm/s) 73.1 ±21.3 65.8 ±20.5 83.4 ±18.0 <0.001
Swing time (s) .38 ± .06 .37 ± .06 .39 ± .05 0.057
Stride length cm 89.2 ±21.8 81.6 ±22.6 100.0 ±16.3 <0.001
Stride time variability (%CV) 4.2 ±2.5 4.7 ±2.8 3.4 ±1.7 0.005
Double support time variability (%CV) 7.6 ±4.0 8.0 ±4.6 7.0 ±3.0 0.234
sagittal plane gait parameters n = 96 n = 58 n = 38
Toe off angle (°) 42.1 ±8.1 40.6 ±8.8 44.8 ±6.2 0.005
Heel strike angle (°) 11.8 ±4.9 10.7 ±4.9 13.5 ±4.5 0.009
Max. toe clearance (cm) 6.1 ±2.0 5.6 ±1.9 6.9 ±2.1 0.003
FTU = first time WW user, FU = frequent WW user, (°) = degree, (cm) = centimeter, (% CV) = coefficient of variation, calculated by the formula: [CV (%) = SD/
Mx100]; Significance was calculated for the difference in gait parameters between FU and FTUs (unpaired t-test, 2-sided)
Table 3 Gait parameter improvement by WW in FU and FTU
Fold improvement by WW
Variable Total FU FTU Significance
Main effect Interaction effect
Mean ± SD Mean ± SD Mean ± SD F (p)
Spatio-temporal gait parameters n = 106 n = 62 n = 44
Velocity (cm/s) x 1.18 ± 0.29 1.25 ± 0.34 1.06 ± 0.16 44.51 (<0.001) 10.91 (0.001)
Swing time (s) x 1.07 ± 0.15 1.09 ± 0.17 1.04 ± 0.10 20.61 (<0.001) 1.87 (0.174)
Stride length (cm) x 1.18 ± 0.28 1.25 ± 0.32 1.08 ± 0.15 56.13 (<0.001) 8.96 (0.003)
Stride time variability (% CV) x 1.04 ± 1.80 1.10 ± 2.28 0.95 ± 0.74 12.68 (0.001) 8.63 (0.004)
Double support time variability (% CV) x 1.04 ± 1.24 1.14 ± 1.52 0.90 ± 0.68 0.31 (0.576 0.54 (0.464)
Sagittal plane gait parameters n = 96 n = 58 n = 38
Toe off angle (°) x 1.09 ± 0.14 1.12 ± 0.16 1.04 ± 0.10 32.88 (<0.001) 6.46 (0.013)
Heel strike angle (°) x 1.53 ± 2.35 1.57 ± 2.8 1.45 ± 1.45 42.11 (<0.001) 0.37 (0.544)
Max. toe clearance (cm) x 1.0 ± 0.24 1.05 ± 0.26 0.92 ± 0.18 3.16 (0.079) 6.67 (0.011)
Mean individual fold of change (“x”) by usage of a WW over walk unaided; FTU = first time WW user, FU = frequent WW user; (°) = degree, cm = centimeter, (%
CV) = coefficient of variation, calculated by the formula: [CV (%) = SD/Mx100]. F-values (1, 104) and p-values are presented for the main effect = walk unaided v.s.
WW walk; Interaction effect = walk unaided v.s. WW walk * FU v.s FTU
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Discussion
In this cross-sectional cohort study of hospitalized geri-
atric patients with multifactorial gait impairment, we
investigated the impact of a WW on risk-of-falling asso-
ciated and additional sagittal plane gait parameters. We
demonstrated that the use of a WW improved distinct
gait parameters in geriatric patients. This improvement
was stronger in patients that were accustomed to the
use of a WW (FU subgroup) compared to first time
users (FTU subgroup), also reflecting the higher level of
functional gait impairment in FUs. Importantly, less af-
fected FTUs who were not familiarized with the use of a
WW showed similar patterns of gait parameter improve-
ment as FUs, although to a milder extent. In addition,
the ability to assess sagittal plane gait parameters by in-
ertial sensor-based gait analysis (eGaIT) allowed us to
identify novel objective gait parameters that might be as-
sociated to risk of falling and also improved by the use
of a WW in geriatric patients.
Gait impairment in older adults substantially reduces
the quality of life, limits mobility, and is associated with
increased risk of falling [2]. Multifactorial gait impair-
ment in geriatric patients eventually leads to slower and
more instable gait reflected by reduced gait speed and
increased stride-to-stride variability of gait parameters
[3]. At present, standardized clinical assessment proce-
dures of hospitalized geriatric patients include a broad
set of screening tools [36] not only focusing on an indi-
vidual diagnosis leading to gait impairment, but rather
addressing functional impairments and reduced quality
of life [13]. Instrumented functional assessment of gait is
able to complement diagnostic screens by providing ob-
jective gait parameters reflecting overall gait impairment
independent of the diagnosis but in correlation with the
functional assessment scores (Additional file 1: Table S1),
thus, being relevant for therapeutic interventions and
monitoring [7]. In the present study, geriatric patients
with different signs of gait impairment were subjected to
instrumented gait tests using an instrumented walkway
and inertial sensor-based gait analysis. Here, we showed
that all patients have dysfunctional gait characteristics that
could be quantified by objective gait parameter assess-
ment. In particular, velocity was reduced compared to his-
torical normative data (82.9 cm/s vs. 109.5 cm/s) [57] in
all patients, independent of the distinct diagnoses. The
multimorbid and frail characteristics of our patient cohort
are indicated by a mean number of 11 diagnoses and the
patient’s higher functional mobility impairment, as
assessed by POMA and TUG (Table 1) and also a stronger
level of gait parameter impairment (Table 2). A decline in
velocity often reflects a reduction in physical mobility in
elderly people. Gait velocity values for healthy older adults
have been reported around 1.3 m/s [49]. Healthier aging
and survival in community-dwelling elderly has been
associated with velocities faster than 0.8 – 1.0 m/s, and
the likelihood of frailty and poor overall health strongly
correlates with gait velocity slower than 0.6 m/s [58–60].
In our cohort of gait impaired patients, gait speed was re-
duced in both subgroups. Patients that were accustomed
to the use of a WW showed even stronger reduced vel-
ocity (Table 2). This may be explained by the presence of
more severe gait impairment in patients depending on
the use of a WW for a longer period, which is also consist-
ent with previous findings reporting that community-
dwelling elderly using walking aids such as a cane, crutch,
or WW had a significant slower gait during unassisted
walking [14].
The present study focused in particular on established
risk of falling associated gait parameters velocity, swing
time, stride length, as well as stride time and double
support time variabilities. In addition, we were also able
to record additional sagittal plane gait parameters that
might also be associated to falling [26]. Stride length and
velocity increased by the use of a WW in the present
cohort. It has been shown that enlarged stride length
leads to an increase in velocity [14, 15].
Interestingly, we could not detect difference in the two
gait parameters stride time and double support time
variabilities. Gait variabilities have been associated not
only with irregular and unstable gait but also with an in-
creased risk of falling [9, 12, 61], frailty [51], and with
other neurodegenerative diseases [62, 63]. It is important
to note that gait variabilities in the present laboratory
gait test are deducted from only 10 m walking distance.
This clearly limits the informative value of gait variabil-
ities as a surrogate marker which is also reflected by the
large deviations observed in the present cohort (Table 2
and 3). Ideally, longer gait sequences would be required
to assess more reliable gait variabilities, but might also
lead to exhaustion or fatigue, in particular in a cohort
with already severe gait and mobility impairments. Thus,
based on this limitation of the study our data support
the hypothesis that gait variabilities cannot be measured
form only 11–13 strides as evaluated in the present gait
analysis setting. Future analysis concepts using numer-
ous gait sequences from continuous gait monitoring
over days and weeks might help to solve this principle
challenge. However, our findings indicate that a 10 m
walk as a standardized test frequently used in routine
clinical diagnostics has already the potential to improve
the diagnostics for WW usage in clinical care.
Interestingly, not only the spatio-temporal falling asso-
ciated gait parameters improved by the use of a WW in
all patients, but also the swing phase associated gait pa-
rameters in the sagittal plane such as toe off and heel
strike angle. Increasing hip flexion and extensor mo-
ments, the reduction in knee flexion in early stance, and
less ankle range of motion (ROM) and ankle plantar
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flexor power were reported as age related adaption of
gait [64–68]. Increasing stride length and velocity in FUs
and FTUs using the WW may result in an increase in
ankle ROM and thus affect toe off and heel strike angles.
The increase in heel strike angle during WW use could
be explained by an involuntary reactive deceleration
through an accentuated use of the heel protecting the
user against unwanted further acceleration.
Unexpectedly, investigating swing phase associated
gait parameters in FTUs showed a reduction in maximal
toe clearance. It has been described that patients with
impaired gait characteristics exhibit a punting or tamp-
ing behavior in order to actively increase the maximal
toe clearance [69]. Under healthy conditions, a person
walking with an upright posture relies only on his feet
for a base of support (BOS). In this position, the somato-
sensory input is received primarily from the lower ex-
tremities. During normal gait performance without a
WW, the reciprocal swing of the upper extremities could
allow them to constantly be alert and ready to help
maintain the center of mass (COM) over the BOS when
balance is affected. However, using a WW might change
these body mechanics. The alternating arm-swing will be
lost by WW usage and bilateral somatosensory input
from the lower extremities may gradually adapt to quad-
rilateral somatosensory inputs from both lower and
upper extremities. Furthermore, the use of an WW al-
lows the upper extremities to compensate for weak
lower extremity muscles and allows total bodyweight to
be supported by upper and lower extremities rather than
the lower extremities alone [70]. Thus, using a WW
leads to a considerable enlargement of the base of sup-
port (BOS) between the patient’s feet and the four
wheels of the device. This allows to position the body’s
COM over the BOS to achieve static postural equilib-
rium [15, 71]. Our findings show that using a WW in
FTUs resulted in a reduction in maximal toe clearance.
One can speculate that this could be a consequence of
the biomechanical and psychological support by the WW
where patients experience an unprecedented sense of
comfort and safety. It is also not clear, whether and how
this also contributes to an increased risk of falling after
WW use which has been shown by other authors [72–74].
The WW test paradigm for FTUs in the present study
mimics the typical diagnostic test setting, where a pa-
tient with gait impairment is routinely subjected to func-
tional mobility testing including the use of a WW.
Future studies have to confirm the findings in this se-
lected population where the recruitment of patients with
heterogeneity of diagnoses depends on the experience of
the attending physician in a more active community-
dwelling population. Nevertheless, using this paradigm
of patient selection and the complementary approach
using mobile and stationary assessed gait parameters we
were able to isolate distinct gait characteristics that are
especially sensitive for the use of a WW. Therefore, the
change of these gait parameters could be used as surro-
gate markers for the effect of a WW.
The interpretation of our findings that the use of a
WW can be objectively measured by instrumented gait
parameters is limited by several considerations: For the
FTU group familiarization aspects might be confounding
factors for the change of gait parameters. It has been re-
ported that first time WW usage can lead to dissatisfaction
and requires to get used to the WW [75]. Furthermore, the
use of a WW can be stigmatizing and thereby negatively
affect the use of a WW. In addition, the importance of an
introduction, training in basic functions and handling of
the WW prior to first time use has an impact on the applic-
ability of a WW [74, 75]. Even though we included a short
time of familiarization with the WW for FTU, we cannot
exclude that low familiarization affects the outcome gait pa-
rameters. Therefore, it is important that FTUs improved in
velocity, swing time, stride length, heel strike- and toe off
angle in a similar manner compared to FUs, suggesting that
the low level of familiarization did not substantially affect
the applicability of gait parameters as surrogate markers for
WW use also in the FTU group. Finally, the changes in gait
parameter do not provide information on the long term
consequences in particular in the light of poorer functional
status in the FU compared to the FTUs. Future prospective
studies to examine familiarization affects and long term
consequences are still needed.
Conclusion
Using a WW improved distinct risk of falling associated
gait parameters in the present hospitalized geriatric pa-
tient cohorts. Although gait performance of FTUs and
FUs did not reach the level of a normal, healthy and
stable gait, our findings indicate the potential of objective
gait parameter assessment to improve and complement
the diagnostic workup also providing target parameters to
monitor intervention efficacy. Future longitudinal studies
are warranted to validate the predictive value on known
risk of falling associated and novel sagittal plane gait pa-
rameters under WW usage.
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